Upcoming Discipline Hearings

Hearing Dates: July 21, 2025, July 22, 2025, July 23, 2025, July 24, 2025, July 29, 2025, July 31, 2025,

Summary of Allegations

As a result of a referral by the Accreditation Committee, it is alleged that Noor Nooruzzaman, as Designated Manager of Noor Healthcare Pharmacy in Mississauga, Ontario (the “Pharmacy”), and as the Director of Nooruzzaman Inc., c.o.b. Noor Healthcare Pharmacy, and Nooruzzaman Inc., as the holder of Certificate of Accreditation #303588 for the Pharmacy, committed proprietary misconduct in that they:

1. Permitted, consented to or approved, either expressly or by implication, the operation of the Pharmacy without a pharmacist physically present on or about September 30, 2021; and/or
2. Failed to adequately maintain the pharmacy in a safe, clean, and/or orderly fashion with respect to:
   1. the inadequate storage of medication awaiting destruction and sharps containers in or about September 2021; and/or
   2. the inadequate monitoring/and or maintenance of fridge temperatures between in or about October 2019 and/or in or about September 2021; and/or
3. Failed to have adequate systems in place and/or adequate recordkeeping with respect to:
   1. Conducting and/or maintaining a record of, adequate inventory counts and/or reconciliations for narcotics, controlled drugs and/or targeted substances from in or about January 9, 2019 to in or about October 29, 2019; and/or in or about March, April, August and/or September 2021; and/or
   2. recording accurate information regarding prescriptions, specifically with respect to unsigned prescription hard copies on one or more occasions in and around April 2019, October 2019 and/or September 2021; and/or
   3. maintaining records in a manner that is auditable, traceable and/or allows for their easy retrieval with respect to Rx […] in and around October 2019 and Rxs […], […], and/or […] in and around September 2021

In particular, it is alleged that Noor Nooruzzaman, as Designated Manager of Noor Healthcare Pharmacy in Mississauga, Ontario (the “Pharmacy”), and as the Director of Nooruzzaman Inc., c.o.b. Noor Healthcare Pharmacy, and Nooruzzaman Inc., as the holder of Certificate of Accreditation #303588 for the Pharmacy:

• Failed to maintain any of the standards of accreditation;
• Failed to keep documents as required respecting patients, the operation of the pharmacy and/or the practice of members practicing in the pharmacy;
• Contravened the Drug and Pharmacies Regulation Act, the Pharmacy Act, 1991, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act, the Ontario Drug Benefits Act or the regulations under those Acts, in particular: section 146(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
• Contravened a federal, provincial or territorial law or any municipal bylaw with respect to the distribution, purchase, sale and/or dispensing of any drug product, where the purpose of the law or bylaw is to protect or promote public health or where the law or bylaw relates to the operation of the pharmacy or the provision of pharmacy services, in particular:
  • section 43 of the Narcotic Control Regulations, as amended; and/or
  • section G.03.012 under the Food and Drug Regulations, as amended; and/or
  • section 72 of the Benzodiazepines and Other Targeted Substances Regulations, as amended;
• Engaged in conduct or performed an act relevant to the operation of a pharmacy that, having regard to the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: July 21, 2025, July 22, 2025, July 23, 2025, July 24, 2025, July 29, 2025, July 31, 2025,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Noor Nooruzzaman committed professional misconduct in that he failed to abide by or carry out the terms of the Undertaking, Agreement and Acknowledgment (the “Undertaking”) given to the College dated October 31, 2022, in which he undertook to complete a mentorship program with a pharmacist in relation to record keeping, inventory management and billing processes, and the College’s Designated Manager e-Learning Module within six months of the date of the Undertaking.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to carry out or abide by an undertaking given to the College or breached an agreement with the College, a Committee of the College or the Registrar;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: August 12, 2025, August 13, 2025, August 18, 2025, August 19, 2025, August 20, 2025,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Olivier Salgado, while employed as a pharmacy technician, committed professional misconduct in that:

• on or about May 9, 2020, he offered and/or gave to [Name] a substance he represented or held out to be Xanax (alprazolam) but was flualprazolam, a benzodiazepine and recreational drug not approved for medical use, after [Name] advised him she had been suffering from [medical condition] or another condition;
• on or about May 9 and/or 10, 2020, he engaged in sexual intercourse or other forms of sexual relations and/or touching of a sexual nature with [Name] without the consent of [Name].

In particular, it is alleged that he:

• Contravened a federal or provincial law or municipal by-law with respect to distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, and in particular: section 5(1) of the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
• Dispensed a drug or administered a substance that he knew or ought to know was not of good quality or did not meet the standards required by law;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming of a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Adnan Ahmed committed professional misconduct between in or about [Specified Date 1] and in or about [Specified Date 2], while he was the Owner, Designated Manager and/or a dispensing pharmacist [Pharmacy], in that he engaged in sexual harassment of [Name], an employee of the Pharmacy, by:

• Touching or attempting to touch [Name] in an inappropriate and/or sexual manner;
• Instructing [Name] to touch him in an inappropriate and/or sexual manner; and/or
• Making remarks or gestures to [Name] of an inappropriate and/or sexual nature.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming of a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mojgan Bijanzadeh committed professional misconduct in that:

1. She failed to comply with some, or all of the following terms, conditions or limitations set out in the an order of a panel of the Discipline Committee of the Ontario College of Pharmacists dated June 7, 2021 (the “Order”):
   1. provide the count and reconciliation of all narcotics, controlled drugs and targeted substances at her pharmacy as set out in paragraph 2(b) of the Order;
   2. complete an individualized ethics course with Gail E. Siskind Consulting Services, or another professional ethics consultant chosen by the College, as set out in paragraph 2(c) of the Order;
   3. complete the ProBE course on professional/problem-based ethics for health care professionals, with an unconditional pass, as set out in paragraph 2(d) of the Order;
   4. complete the CAMH Opioid Dependence Treatment Core Course, as set out in paragraph 2(e) of the Order;
   5. complete Module 5: Practice and Pharmacy Management II (including JP #7-Controlled Drugs and Substances Act) from the Canadian Pharmacy Skills Program II; or an equivalent course approved by the Ontario College of Pharmacists, as set out in paragraph 2(f) of the Order; and/or
   6. complete the Jurisprudence exam offered by the College, as set out in paragraph 2(g) of the Order;
2. She failed to pay costs to the College in the amount of $61,750.00, as set out in paragraph 5 of the Order;
3. On or about November 18, 2022, she engaged in the practice of pharmacy while her certificate was suspended;
4. On or about November 18, 2022, to on or about March 2, 2023, while her certificate of registration was suspended, she:
   1. dispensed and/or sold a drug and/or supervised the part of a pharmacy where drugs are kept contrary to section 4 of the Pharmacy Act, subsection 27(1) of the Regulated Health Professions Act, and/or subsection 149(1) of the Drug and Pharmacies Regulation Act; and/or
   2. operated a pharmacy when it was not managed by a pharmacist designated as the designated manager by the owner of the pharmacy contrary to section 146(b) of the Drug and Pharmacies Regulation Act;
5. She failed to pay costs to the College in the amount of $10,000.00, as ordered by the Divisional Court on or about August 2, 2022; and/or
6. She failed to pay costs to the College in the amount of $5,000.00, as ordered by the Court of Appeal on or about October 18, 2022.

In particular, it is alleged that she:

• Contravened a term, condition or limitation imposed on her certificate of registration;
• Failed to maintain a standard of practice of the profession;
• Failed to comply with an order of a panel of the Discipline Committee of the Ontario College of Pharmacists dated June 7, 2021;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Kai Shun Chow, while engaged in the practice of pharmacy at Brock Medical Pharmacy in Toronto, Ontario (the “Pharmacy”), and/or as the Designated Manager of the Pharmacy, and/or as a director and/or shareholder of the corporation that operated the Pharmacy, committed professional misconduct with respect to the following:

1. between about March 3, 2023 and April 12, 2023, failing to maintain hours of operation for the Pharmacy that were consistent and communicated to the public;
2. from about December 22, 2021 onward, routinely failing to sign hardcopies at the time of dispensing and/or at the time of conducting a check for accuracy and therapeutic appropriateness;
3. from about December 22, 2021 onward, routinely dispensing drugs without ensuring the signature of the person dispensing the drug was recorded on the prescription as required by s. 156(1) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;
4. failing to ensure that the information required by s. 156(1) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4 was recorded on the prescription, and/or failing to retain such records for a minimum of ten years as required by s. 156(2), contrary to one or both of those sections, with respect certain identified prescriptions;
5. between about October 5, 2020 and July 17, 2023, with respect to Patients [Patient 1] and [Patient 2], dispensing a smaller quantity than the full amount authorized by the prescription, with no documentation of patient authorization to do so, contrary to s. 9 of the Drug Interchangeability and Dispensing Fee Act, RSO 1990, c P.23;
6. between about October 5, 2020 and July 17, 2023, with respect to certain identified patients, dispensing prescriptions and refills more frequently than should have been necessary based on the date on which the last supply of the drug was dispensed to the patient, without documentation to support such early dispensing;
7. dispensing drugs without authorization, by processing a single authorization as multiple prescriptions and/or dispensing more than the quantity authorized, with respect to certain identified prescriptions;
8. dispensing drugs without authorization, by processing falsified authorizations, with respect to certain identified prescriptions;
9. dispensing drugs without authorization, by falsifying verbal authorizations with respect to:
   1. 20 of 22 verbal authorizations documented to have been received from [Doctor 1] for Patient [Patient 3] between September 29, 2021 and January 3, 2023;
   2. 67 verbal authorizations documented to have been received from [Doctor 2] for Patient [Patient 4], Patient [Patient 5], and Patient [Patient 2], between September 30, 2021 and January 13, 2023;
10. dispensing drugs without authorization, by accepting and/or falsifying verbal authorizations from [Doctor 3] after [Doctor 3] was no longer authorized to prescribe medication, with respect to all verbal authorizations processed from September 20, 2022 onward;
11. incorrectly documenting the directions for use with respect to Rx# [number];
12. dispensing ranitidine and cimetidine concurrently to Patient [Patient 6], when both drugs are H₂-receptor antagonists and should not be taken together, between about March 25, 2021 and June 26, 2021;
13. failing to comply with the requirements for closing a community pharmacy after the Pharmacy ceased operations, including failing to remove all signs and symbols relating to the practice of pharmacy within or outside the premises, failing to remove all drugs and/or dispose of all drugs in an environmentally safe manner, and/or failing to take steps to secure all patient records;
14. between about March 3, 2023 and November 8, 2023, failing to respond reasonably promptly (and/or at all) to correspondence from the Ontario College of Pharmacists that related to his practice and required a response;
15. between about December 21, 2021 and July 17, 2023, permitting a person whose certificate of registration was revoked for cause, namely [Person 1], to work in the Pharmacy, contrary to s. 143 of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;
16. in the alternative to the allegations above that allege that prescriptions were dispensed, to the extent that the prescriptions identified in those allegations were not in fact dispensed, submitting false claims for which the Pharmacy was not entitled to payment, with respect to all such prescriptions identified in the allegations above;
17. between about October 4, 2021 and December 30, 2022, submitting (or in his capacity as Designated Manager of the Pharmacy and/or director and/or shareholder of the corporation operating the Pharmacy being responsible for the submission of) claims for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products.

In particular, it is alleged that he:

• failed to maintain a standard of practice of the profession;
• failed to keep records as required;
• falsified a record relating to his practice or a person’s health record;
• submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • 143, s. 155(1), s. 156(1) and/or s. 156(2) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;
  • 9 of the Drug Interchangeability and Dispensing Fee Act, RSO 1990, c P.23;
• contravened a federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, and in particular: s. C.01.041 of the Food and Drug Regulations, CRC, c. 870, made under the Food and Drugs Act, RSC 1985, c F-27;
• failed to reply within a reasonable time to a written or electronic inquiry or request from the Ontario College of Pharmacists;
• engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Boyana Djokic, between January 1, 2019 and May 10, 2022, in her role as Designated Manager and/or pharmacist at the York Downs Chemists (the “Pharmacy”), committed professional misconduct in that she:

• Failed to maintain a standard of practice of the profession, with respect to the manufacture, making or compounding of, labelling of, sale or dispensing of and/or recordkeeping in relation to any or all of certain identified drugs and/or products, including but not limited to the following standards of practice:

1. • the National Association of Pharmacy Regulatory Authorities (“NAPRA”) Model Standards of Practice for Canadian Pharmacists;
   • NAPRA Model Standards for Pharmacy Compounding of Non-hazardous Sterile Preparations;
   • NAPRA Model Standards for Pharmacy Compounding of Non-Sterile Preparations; and/or
   • NAPRA Model Standards for Pharmacy Compounding of Hazardous Sterile Preparations;

as those standards of practice may be explained or elaborated upon in the following practice policies, guidelines and advisories:

1. • the College’s Designated Manager – Medication Procurement and Inventory Management Policy (June 2011);
   • the College’s Cross-Jurisdictional Pharmacy Services Policy (August 2022) the Out of Province Prescriptions Fact Sheet and the Out of Country Prescriptions policy;
   • the College’s Medical Directives and the Delegation of Controlled Acts Policy (October 2007);
   • the College’s Pharmacy Connection: Master Formulation Records and Compounding Records (Winter/Spring 2021);
   • the College’s Advisory on Ivermectin (September 10, 2021);
   • Health Canada’s Public Advisory on Ivermectin not authorized to prevent or treat COVID-19; may cause serious health problems (August 31, 2021); and
   • Health Canada’s Policy on Manufacturing and Compounding Drug Products in Canada (POL-0051).

• Failed to keep records as required respecting her patients or practice, including but not limited to records in relation to any or all of certain identified drugs and/or products.
• Signed or issued, in her professional capacity, a document that she know or ought to know contains a false or misleading statement, with respect to her use of Drug Identification Numbers (DINs) listed in Pharmacy records and/or on drug and/or product labels, including but not limited to records in relation to any or all of certain identified drugs and/or products.
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, in particular but not limited to sections 155, 156, 158 and 160 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, and Ontario Regulation 264/16 under that Act with respect to the requirements for labelling, distribution, dispensing (including the requirement that such dispensing be pursuant to a valid prescription containing the requisite information), sale, and/or the wholesale of a drug or product, in particular but not limited to any or all of certain identified drugs and/or products.
• Advertised a pharmacy or its services in a manner that is false, misleading or deceptive, including by advertising for sale drugs and/or products not approved for sale in Canada, including but not limited to any or all of certain identified drugs and/or products.
• Engaged in the manufacture, distribution, purchase, importation, sale and/or dispensing of drugs and/or products without a valid prescription and/or where some or all of the drugs or products involved had not been approved for sale and/or distribution in Canada, including but not limited to any or all of certain identified drugs and/or products.
• Dispensed, sold or compounded a drug, or administered a substance, that she knew or ought to have known is not of good quality or does not meet the standards required by law or, in the case of a drug, does not contain a substance that the drug is meant to contain, in respect of any or all of certain identified drugs and/or products.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting her patients or practice;
• Signed or issued, in her professional capacity, a document that she know or ought to know contains a false or misleading statement;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, in particular but not limited to sections 155, 156, 158 and 160 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, and Ontario Regulation 264/16 under that Act;
• Permitted, consented to or approved, either expressly or by implication, an act or acts that contravene(s) Part V of the Ontario Regulation 264/16 (General) made under the Pharmacies Regulation Act, in particular but not limited to, by contravening section 29(1)(a) of Ontario Regulation 264/16 (General);
• Contravened a federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, or whose purpose is to protect or promote public health, including  but not limited to the Food and Drugs Act, RSC, 1985, c F-27, Food and Drugs Regulations, CRC, c 870, Natural Health Products Regulations, SOR/2003-196;
• Dispensed, sold or compounded a drug, or administered a substance, that she knew or ought to have known is not of good quality or does not meet the standards required by law or, in the case of a drug, does not contain a substance that the drug is meant to contain;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Raed Eid, while engaged in the practice of pharmacy as a pharmacist at [Pharmacy A] and/or [Pharmacy B] in [Location], Ontario and after the termination of his employment at the pharmacies, committed professional misconduct in that he:

• attended at [Pharmacy A] on two occasions and yelled at his former employer in public; and/or
• repeatedly called and/or texted his former employer; and/or
• attended at [Pharmacy B] on one or more occasions and video recorded and/or yelled at the owner and staff in the presence of patients; and/or
• sent emails to a number of persons in which he described his former employer and [Related Person] as being, among other things, disgusting and/or disrespectful and/or condescending and/or dishonest and/or racist, and/or incompetent, and/or falsely claimed that his former employer was going to stab him.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Raed Eid, during August 2021, while engaged in the practice of pharmacy as a pharmacist at [Pharmacy Name] in [Location], Ontario, committed professional misconduct in that he:

• Failed to provide a patient known as [Patient 1] with all of the Ramipril she was prescribed and/or verify dose and/or failed to provide [Patient 1] with medication for her daughter and/or was rude to [Patient 1];
• Failed to provide a patient known as [Patient 2] with her medication for depression and/or was rude to [Patient 2];
• Failed to provide a patient known as [Patient 3] with her medication, including but not limited to Elavil;
• Failed to provide patients known as [Patient 4] and [Patient 5] with their medications, including but not limited to [Patient 5]’s insulin;
• Failed to provide a patient known as [Patient 6] with his Keppra and/or provided the patient with the wrong quantity of Kadian;
• Failed to provide a patient known as [Patient 7] with her Cipralex and was rude to [Patient 7]; and/or
• Failed to maintain confidential patient information by questioning [Patient 8]’s mother in public about [Patient 8]’s medical conditions and other personal health information.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Alamgir Hallan committed professional misconduct, between in or about October 2021 and in or about May 2023, while engaged in the practice of pharmacy as owner, director, shareholder, and/or pharmacist at Fort William Medical Pharmacy in Thunder Bay, Ontario, committed professional misconduct in that he:

• Submitted (or permitted, consented to, or approved, expressly or by implication, the submission of) claims for payment to the Ontario Drug Benefit Program for MedsCheck services that were never conducted and/or were non-compliant with the requirements set forth by the Ministry of Health;
• Falsified (or permitted, consented to, or approved, expressly or by implication, the falsification of) records relating to MedsCheck services; and/or
• Failed to (or permitted, consented to, or approved, expressly or by implication, the failure to) keep records and/or documentation as required for MedsCheck services.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed and/or issued, in his professional capacity, a document that he knew or ought to have known contained a false and/or misleading statement;
• Submitted an account and/or charge for services and/or products that he knew or ought to have known was false and/or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Magdy Yashoue Rizkalla Hanna, while engaged in the practice of pharmacy […] at [Pharmacy] in [Location], from about [Specified Date 1] to about [Specified Date 2], committed professional misconduct in that he:

• sexually harassed, sexually abused, and/or failed to maintain professional boundaries with a patient […], [Person];
• provided [Person] with a prescription medication [drug] in absence of a valid prescription.

In particular, it is alleged that he:

• sexually abused a patient, [Person];
• failed to maintain a standard of practice of the profession;
• engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Maged Hanna, while his certificate of registration was suspended, committed professional misconduct in that he:

• Worked at Disera Medical Pharmacy in Thornhill, Ontario (the “Pharmacy”);
• Held himself out as a pharmacist to patients and/or customers of the Pharmacy;
• Dispensed drugs at the Pharmacy;
• Counselled patients on their medications at the Pharmacy; and/or
• Otherwise engaged in the practice of pharmacy at the Pharmacy.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Contravened section 143 of the Drug and Pharmacies Regulation Act;
• Failed to comply with an Order of a panel of the Discipline Committee;
• Practised the profession while his certificate of registration was under suspension;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Kaldus, while practicing pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Elliot Lake Health Centre Pharmachoice in Elliot Lake, Ontario and/or Robinson’s Pharmasave in Espanola, Ontario, in the period from about August 2014 to February 2018, committed professional misconduct in that he:

• Failed to keep records as required by the College’s Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs;
• Directed non-pharmacist employees to dispense methadone to patients;
• Misappropriated prescription drugs and/or controlled substances from the pharmacy, including:
  • Oxycocet;
  • Tylenol #3 and/or Ratio-Lenoltec #3;
  • Clonazepam; and/or
  • Tramadol.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required;
• Contravened s. 149(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, specifically
  • s. 4 of the Controlled Drugs and Substances Act;
  • s. 51(1) of the Benzodiazepines and Other Targeted Substances Regulations, SOR/2000-217;
  • s. 31(1) of the Narcotic Control Regulations, C.R.C., c. 1041
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Chi Luu committed professional misconduct between in or about October 2021 and in or about May 2023, while engaged in the practice of pharmacy at Fort William Medical Pharmacy in Thunder Bay, Ontario, in that he:

• Submitted claims for payment to the Ontario Drug Benefit Program for MedsCheck services that were never conducted and/or were non-compliant with the requirements set forth by the Ministry of Health;
• Falsified records relating to MedsCheck services; and/or
• Failed to keep records and/or documentation as required for MedsCheck services.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed and/or issued, in his professional capacity, a document that he knew or ought to have known contained a false and/or misleading statement;
• Submitted an account and/or charge for services and/or products that he knew or ought to have known was false and/or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Jaspreet Sahota committed professional misconduct, between in or about October 2021 and in or about May 2023, while engaged in the practice of pharmacy as owner, director, shareholder, Designated Manager, and/or pharmacist at Fort William Medical Pharmacy in Thunder Bay, Ontario, in that he:

• Submitted (or permitted, consented to, or approved, expressly or by implication, the submission of) claims for payment to the Ontario Drug Benefit Program for MedsCheck services that were never conducted and/or were non-compliant with the requirements set forth by the Ministry of Health;
• Falsified (or permitted, consented to, or approved, expressly or by implication, the falsification of) records relating to MedsCheck services;
• Failed to (or permitted, consented to, or approved, expressly or by implication, the failure to) keep records and/or documentation as required for MedsCheck services; and/or
• Misappropriated and/or took drugs without authorization from the Pharmacy, including but not limited to controlled drugs and substances.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed and/or issued, in his professional capacity, a document that he knew or ought to have known contained a false and/or misleading statement;
• Submitted an account and/or charge for services and/or products that he knew or ought to have known was false and/or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Sina Salehi, committed professional misconduct with respect to the following incidents:

• While engaged in the practice of pharmacy as Designated Manager at Doctors Pharmacy in Scarborough, Ontario (“Doctors Scarborough”), and/or as a shareholder and/or director of the corporation that operated the pharmacy,

1. 1. between about January 1, 2019, and January 15, 2021, he diverted (or permitted, consented to, or approved, expressly or impliedly, the diversion of) prescription drugs to unauthorized recipients and/or sources, with respect to certain identified prescription drugs;
   2. between about January 1, 2019, and January 15, 2021, he submitted (or permitted, consented to, or approved, expressly or impliedly, the submission of) false or unsubstantiated claims for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
   3. between about January 1, 2019, and January 15, 2021, he dispensed (or permitted, consented to, or approved, expressly or impliedly, the dispensing of) prescription drugs without valid authorization, with respect to certain identified prescriptions;
   4. between about January 1, 2019, and January 15, 2021, he failed to ensure that inventory reconciliations of narcotics and controlled substances were performed at least once every six months, and/or he failed to ensure that records of such reconciliations were retained as required;
   5. between about January 1, 2019, and January 15, 2021, he failed to report the loss or theft of narcotics as required by s. 42 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, and/or he failed to take all reasonable steps necessary to protect narcotics on his premises or under his control against loss or theft as required by s. 43 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act;

• While engaged in the practice of pharmacy as Designated Manager at Doctors Pharmacy in Thornhill, Ontario (“Doctors Thornhill”), and/or as a shareholder and/or director of the corporation that operated the pharmacy,

1. 1. between about April 1, 2019, and January 15, 2021, he diverted (or permitted, consented to, or approved, expressly or impliedly, the diversion of) prescription drugs to unauthorized recipients and/or sources, with respect to certain identified prescription drugs;
   2. between about April 1, 2019, and January 15, 2021, he submitted (or permitted, consented to, or approved, expressly or impliedly, the submission of) false or unsubstantiated claims for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
   3. between about April 1, 2019, and January 15, 2021, he dispensed (or permitted, consented to, or approved, expressly or impliedly, the dispensing of) prescription drugs without valid authorization, with respect to certain identified prescriptions;
   4. between about April 1, 2019, and January 15, 2021, he failed to ensure that inventory reconciliations of narcotics and controlled substances were performed at least once every six months, and/or he failed to ensure that records of such reconciliations were retained as required;
   5. between about April 1, 2019, and January 15, 2021, he failed to report the loss or theft of narcotics as required by s. 42 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, and/or he failed to take all reasonable steps necessary to protect narcotics on his premises or under his control against loss or theft as required by s. 43 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act;

• While engaged in the practice of pharmacy at Neighbour’s Drug Mart in Thornhill, Ontario (“Neighbour’s Drug Mart”), and/or as a shareholder and/or director of the corporation that operated the pharmacy,

1. 1. between about August 4, 2020, and January 15, 2021, he diverted (or permitted, consented to, or approved, expressly or impliedly, the diversion of) prescription drugs to unauthorized recipients and/or sources, with respect to certain identified prescription drugs;
   2. between about August 4, 2020, and January 15, 2021, he submitted (or permitted, consented to, or approved, expressly or impliedly, the submission of) false or unsubstantiated claims for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
   3. between about August 4, 2020, and January 15, 2021, he failed to report the loss or theft of narcotics as required by s. 42 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, and/or he failed to take all reasonable steps necessary to protect narcotics on his premises or under his control against loss or theft as required by s. 43 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act;

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Falsified a record relating to his practice or a person’s health record;
• Submitted an account or charge for services or products that he knew or ought to have known contained a false or misleading statement;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts:
  • s. 155 of the Drug and Pharmacies Regulation Act
• Contravened a federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis:
  • s. C.01.041 of the Food and Drug Regulations, CRC, c 870, made under the Food and Drugs Act
  • s. 42 and/or s. 43 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Sina Salehi, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Neighbour’s Drug Mart in Thornhill, Ontario (the “Pharmacy”), and/or as a shareholder and/or director of the corporation that operated the Pharmacy, committed professional misconduct with respect to the following incidents:

• Between about August 4, 2020 and July 31, 2021, he submitted (or in his capacity as Designated Manager of the Pharmacy and/or a shareholder and/or a director of the corporation that operated the Pharmacy he was responsible for the submission of) claims for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products; and/or
• He submitted (or in his capacity as Designated Manager of the Pharmacy and/or a shareholder and/or a director of the corporation that operated the Pharmacy he was responsible for the submission of) claims to the Ontario Drug Benefit Program that were not eligible to be paid, with respect to certain identified claims.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required;
• Falsified a record relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular he contravened ss. 5, 6, and/or 15(1)(b) of the Ontario Drug Benefits Act, RSO 1990, c O.10, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Sina Salehi, while engaged in the practice of pharmacy at Family Health Pharmacy Thunder Bay (“FHP Thunder Bay”) in Thunder Bay, Ontario, and/or as an owner (directly or indirectly including as an owner of a beneficial interest) in FHP Thunder Bay, and/or as the Designated Manager, or the person exercising the authority and responsibilities of the Designated Manager, of FHP Thunder Bay, committed professional misconduct with respect to the following incidents:

• between about August 22, 2022 and November 7, 2022, he permitted, consented to or approved, expressly or impliedly, FHP Thunder Bay operating without a pharmacist being physically present;
• between about August 22, 2022 and November 7, 2022, he permitted, consented to or approved, expressly or impliedly, the sale and/or dispensing of drugs at FHP Thunder Bay while no pharmacist was physically present;
• between about November 8, 2022 and January 17, 2023, he permitted, consented to or approved, expressly or impliedly, FHP Thunder Bay operating with no Designated Manager;
• on or about January 17, 2023, he closed (or caused and/or participated in the closure of) FHP Thunder Bay, without complying with the requirements for closing a pharmacy and for retaining records, and in particular:

1. 1. he did not submit a pharmacy closing statement to the Registrar within the time required and/or at all, as required by s. 141 of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;

1. 2. he did not comply with the requirements of s. 157(2) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4 relating to the delivery of prescriptions; and/or

1. 3. he did not comply with the requirements of ss. 20 and 21 of O. Reg. 264/16 made under the Drug and Pharmacies Regulation Act, RSO 1990, c H.4 relating to the retention of records;

• on or about at least November 8, 2022, he failed to ensure that FHP Thunder Bay contained equipment that was fit for the purpose of storing drugs and other medication, notably a working refrigerator;
• between about February 16, 2021 and January 17, 2023, he failed to ensure that narcotic counts and/or reconciliations were completed at least every six months at FHP Thunder Bay, and/or that records of such counts and/or reconciliations were retained;
• on or about November 8, 2022, he attempted to mislead an Ontario College of Pharmacists investigator by claiming to have worked as a pharmacist at FHP Thunder Bay on August 31, 2022, when he knew that he had not;
• between about January 1, 2022 and January 17, 2023, he diverted (or permitted, consented to, or approved, expressly or impliedly, the diversion of) Apo-Oxycodone CR 40mg and/or Apo-Oxycodone CR 80mg to unauthorized recipients and/or sources;
• between about August 22, 2022 and January 17, 2023, he diverted (or permitted, consented to, or approved, expressly or impliedly, the diversion of) Teva-Oxycocet 5/325mg to unauthorized recipients and/or sources.

In is further alleged that Sina Salehi, while engaged in the practice of pharmacy at Neighbour’s Drug Mart (“Neighbour’s”) in Thornhill, Ontario, and/or as Designated Manager of Neighbour’s and/or as a shareholder and/or director of the corporation that operated, committed professional misconduct with respect to the following incidents:

• between about October 27, 2022 and August 1, 2023, he closed (or caused and/or participated in the closure of) Neighbour’s, without complying with the requirements for closing a pharmacy on a temporary basis, and in particular:

1. 1. he did not take adequate steps to provide notice to the public of the closure, of alternate pharmacies, of emergency contacts, and of other information that would facilitate continuity of care, including by failing to post one or more signs at Neighbour’s for the duration of the closure, failing to provide accurate information to callers to the pharmacy, and/or failing to update the pharmacy’s website and/or Google profile;

1. 2. he did not comply with the requirements of ss. 20 and 21 of O. Reg. 264/16 made under the Drug and Pharmacies Regulation Act, RSO 1990, c H.4 relating to the retention of records;

• on or about August 1, 2023, he closed (or caused and/or participated in the closure of) Neighbour’s, without complying with the requirements for closing a pharmacy and for retaining records, and in particular:

1. 1. he did not submit a pharmacy closing statement to the Registrar within the time required and/or at all, as required by s. 141 of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;

1. 2. he did not comply with the requirements of s. 157(2) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4 relating to the delivery of prescriptions; and/or

• between about September 16, 2022 and July 14, 2023, he diverted (or permitted, consented to, or approved, expressly or impliedly, the diversion of) drugs, including prescription drugs, narcotics, controlled drugs, and targeted substances, to unauthorized recipients and/or sources, with respect to all drugs purchased by Neighbour’s during that period.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • sections 141, 146, 146(1.1), 149, 157 of the Drug and Pharmacies Regulation Act;
  • sections 18(2), 19(f)(i), 20 and 21 of O. Reg. 264/16 made under the Drug and Pharmacies Regulation Act;
• Contravened a federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, and in particular:
  • section C.01.041 of the Food and Drug Regulations, CRC, c 870, made under the Food and Drugs Act;
  • sections 42 and 43 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.